Health care industry

• UnitedHealth Group commits to improvements after independent audit, patient backlash - The company said it has adopted 23 ongoing "action plans" to track and implement recommended improvements, all of which will be completed by the end of March.
• Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple - Dealmakers expected a flood of M&A to take place in 2025 following the election of President Trump. The number of transactions didn't live up to the hype.
• Trump signs executive order reclassifying cannabis, opening door to broader weed access - President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
• Medical supply firm Medline jumps more than 25% in debut after biggest IPO of 2025 - Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism about 2026.
• Trump says he's 'strongly' considering reclassifying pot via executive order - Pot stocks fell on Monday as investors took profits following a record-setting session.
• FDA approved a $250,000 Singapore work trip during government shutdown, records show - The FDA sent 31 staffers to a Singapore conference during the shutdown, records show, raising questions of optics, spending and the agency's strained resources.
• ‘The next protein’: Fiber is shaping up to be the latest grocery obsession - As consumers find their next grocery obsession in fiber, food and beverage companies are racing to keep up with the trend.
• Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial   - The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill. 
• RFK Jr.'s vaccine panel to vote on changing hepatitis B shot recommendation for babies - The current recommendation for babies to receive a hepatitis B shot within 24 hours of birth is credited with driving down infections in kids by 99%.
• Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.